Biogen revenue slips 6% to $2.53B in Q1



American biotechnology company Biogen Inc. announced on Tuesday its revenue in the first quarter of 2022 fell 6% on the year to $2.53 billion.

The company’s diluted earnings per share landed at $…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento